Eosinophils and immunologic lung disease.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000175:diagnosis / Q000188:drug therapy; D004802:Eosinophilia / Q000150:complications; D004804:Eosinophils / Q000276:immunology / Q000473:pathology*; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000276:immunology; D008171:Lung Diseases / Q000097:blood / Q000276:immunology*; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000150:complications / Q000276:immunology; D009582:Nitrofurantoin / Q000009:adverse effects; D011014:Pneumonia / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D011657:Pulmonary Eosinophilia / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D013577:Syndrome; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000175:diagnosis / Q000209:etiology / Q000473:pathology
D000305:Adrenal Cortex Hormones; D009582:Nitrofurantoin